# GeneCentric Therapeutics, Inc. — Form D

GeneCentric Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-13. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-01-13
- Form: D
- Accession: 0001529224-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.2M
- Investors: 4
- Date of first sale: 2020-12-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-386126

## Issuer

- Name: GeneCentric Therapeutics, Inc.
- CIK: 0001529224
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 100 CAPITOLA DRIVE, DURHAM, NC, 27713
- Phone: (919) 973-6544

## Officers, directors & promoters (25)

| Name | Role | Location |
| --- | --- | --- |
| MYLA LAI-GOLDMAN | Executive Officer | Durham, NC |
| CHARLES PEROU | Executive Officer | Durham, NC |
| Clay Thorp | Director | Durham, NC |
| Ellen Lubman | Director | Morristown, NJ |
| MICHAEL MILBURN | Director | Durham, NC |
| MICHAEL MILBURN | Executive Officer | Durham, NC |
| ARNOLD LEVINE | Director | Durham, NC |
| CHARLES PEROU | Director | Durham, NC |
| Prasanth Reddy | Director | Durham, NC |
| MYLA LAI-GOLDMAN | Director | Durham, NC |
| Don Hardison | Director | Durham, NC |
| Ellen V Lubman | Director | Durham, NC |
| Michael V Milburn | Director | Durham, NC |
| Michael V Milburn | Executive Officer | Durham, NC |
| Perou V Charles | Director | Durham, NC |
| Perou V Charles | Executive Officer | Durham, NC |
| Clay V Thorp | Director | Durham, NC |
| Myla V Lai-Goldman | Director | Durham, NC |
| Myla V Lai-Goldman | Executive Officer | Durham, NC |
| Arnold V Levine | Director | Durham, NC |
| Clay Neil Thorp | Director | Durham, NC |
| Arnold Neil Levine | Director | Durham, NC |
| David Neil Hayes | Director | Durham, NC |
| David Neil Hayes | Executive Officer | Durham, NC |
| Charles Neil Perou | Director | Durham, NC |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-06-20](https://search.stillhousedata.com/formd/0001529224-25-000001) | D | $5.0M | $2.0M |
| [2022-09-20](https://search.stillhousedata.com/formd/0001529224-22-000001) | D | $3.5M | $2.5M |
| [2021-10-07](https://search.stillhousedata.com/formd/0001529224-21-000004) | D | $7.5M | $4.5M |
| [2017-01-05](https://search.stillhousedata.com/formd/0001529224-17-000001) | D | $8.6M | $6.1M |
| [2014-07-11](https://search.stillhousedata.com/formd/0001529224-14-000001) | D/A | $5.0M | $5.0M |
| [2013-07-02](https://search.stillhousedata.com/formd/0001529224-13-000001) | D | $5.0M | $2.5M |
| [2011-09-16](https://search.stillhousedata.com/formd/0001529224-11-000001) | D | $250K | $250K |

## More

- [CIK 1529224 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1529224&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001529224-21-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.